San Marcos, CA, United States of America

Michael Allen Hanson

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Pearl River, NY (US) (2021)
  • South San Francisco, CA (US) (2023)
  • San Marcos, CA (US) (2012 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Michael Allen Hanson: Innovator in APJ Receptor Activity

Introduction

Michael Allen Hanson is a notable inventor based in San Marcos, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the APJ receptor. With a total of nine patents to his name, Hanson is recognized for his innovative approaches to treating various medical conditions.

Latest Patents

Hanson's latest patents focus on compounds and compositions for treating conditions associated with APJ receptor activity. These patents disclose chemical entities that modulate the apelin receptor, which is crucial for addressing diseases where APJ receptor activity is compromised. The applications of these compounds are extensive, targeting conditions such as cardiovascular disease, metabolic disorders, and organ failure. Specific examples include treatments for pulmonary hypertension, heart failure, type II diabetes, renal failure, sepsis, and systemic hypertension.

Career Highlights

Throughout his career, Michael Allen Hanson has worked with prominent organizations such as Annapurna Bio, Inc. and The Scripps Research Institute. His work has been instrumental in advancing the understanding and treatment of diseases linked to APJ receptor activity. His innovative research has paved the way for new therapeutic strategies that could significantly improve patient outcomes.

Collaborations

Hanson has collaborated with esteemed colleagues, including Esther Martinborough and Marcus F Boehm. These partnerships have fostered a collaborative environment that enhances the research and development of new medical treatments.

Conclusion

Michael Allen Hanson stands out as a leading inventor in the field of pharmaceutical innovations, particularly in the modulation of APJ receptor activity. His contributions have the potential to transform the treatment landscape for various serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…